Agilis RF TSP Early Feasibility Study
NCT: NCT07361445 · RECRUITING
Brief Summary
This study is a prospective, acute, first-in-human, early feasibility study intended to assess the initial safety and performance of the Agilis™ Radiofrequency (RF) Transseptal (TSP) System in crossing the atrial septum for left atrial and left ventricular access during cardiac electrophysiology (EP) and interventional cardiology (IC) procedures. This study will be conducted in an acute setting. Subjects will be followed through hospital discharge, and no follow-up visits will be required for this study.
Frequently Asked Questions
What is Agilis RF TSP Early Feasibility Study?
Agilis RF TSP Early Feasibility Study is a clinical trial registered under NCT07361445. Current status: RECRUITING.
What is the status of NCT07361445?
The current status of NCT07361445 (Agilis RF TSP Early Feasibility Study) is: RECRUITING.
When did Agilis RF TSP Early Feasibility Study start?
Agilis RF TSP Early Feasibility Study started on 2026-02-16.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.